Increased activation of NADPH oxidase 4 in the pulmonary vasculature in experimental diaphragmatic hernia

Aim Persistent pulmonary hypertension remains a major cause of mortality and morbidity in congenital diaphragmatic hernia (CDH). NADPH oxidases (Nox) are the main source of superoxide production in vasculature. Nox4 is highly expressed in the smooth muscle and endothelial cells of the vascular wall...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pediatric surgery international 2013, Vol.29 (1), p.3-8
Hauptverfasser: Gosemann, Jan-H, Friedmacher, Florian, Hunziker, Manuela, Alvarez, Luis, Corcionivoschi, Nicolae, Puri, Prem
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 8
container_issue 1
container_start_page 3
container_title Pediatric surgery international
container_volume 29
creator Gosemann, Jan-H
Friedmacher, Florian
Hunziker, Manuela
Alvarez, Luis
Corcionivoschi, Nicolae
Puri, Prem
description Aim Persistent pulmonary hypertension remains a major cause of mortality and morbidity in congenital diaphragmatic hernia (CDH). NADPH oxidases (Nox) are the main source of superoxide production in vasculature. Nox4 is highly expressed in the smooth muscle and endothelial cells of the vascular wall and increased activity has been reported in the pulmonary vasculature of both experimental and human pulmonary hypertension. Peroxisome proliferator-activated receptor (PPARγ) is a key regulator of Nox4 expression. Targeted depletion of PPARγ results in pulmonary hypertension phenotype whereas activation of PPARγ attenuates pulmonary hypertension and reduces Nox4 production. The nitrofen-induced CDH model is an established model to study the pathogenesis of pulmonary hypertension in CDH. It has been previously reported that PPARγ-signaling is disrupted during late gestation and H 2 O 2 production is increased in nitrofen-induced CDH. We designed this study to investigate the hypothesis that Nox4 expression and activation is increased and vascular PPARγ is decreased in nitrofen-induced CDH. Methods Pregnant rats were treated with either nitrofen or vehicle on gestational day 9 (D9). Fetuses were sacrificed on D21 and divided into control and CDH. RT-PCR, western blotting and confocal-immunofluorescence-double-staining were performed to determine pulmonary expression levels of PPARγ, Nox4 and Nox4-activation (p22 phox ). Results There was a marked increase in medial and adventitial thickness in pulmonary arteries of all sizes in CDH compared to controls. Pulmonary Nox4 levels were significantly increased whereas PPARγ levels were decreased in nitrofen-induced CDH compared to controls. Western blotting revealed increased pulmonary protein expression of the Nox4-activating subunit p22 phox and decreased protein expression of PPARγ in CDH compared to controls. Confocal-microscopy confirmed markedly increased pulmonary expression of the Nox4 activating subunit p22 phox accompanied by decreased perivascular PPARγ expression in lungs of nitrofen-exposed fetuses compared to controls. Conclusion To our knowledge, the present study is the first to report increased Nox4 production in the pulmonary vasculature of nitrofen-induced CDH. Down-regulation of the PPARγ-signaling pathway may lead to increased superoxide production, resulting in pulmonary vascular dysfunction and contributing to pulmonary hypertension in the nitrofen-induced CDH model. PPARγ-activation inhibiting No
doi_str_mv 10.1007/s00383-012-3209-0
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1273175389</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3024103411</sourcerecordid><originalsourceid>FETCH-LOGICAL-c372t-e7ac6d7f87c380965c53d56807b085a31d0d8fd0281605b9e31b65b58bd7ad353</originalsourceid><addsrcrecordid>eNp1kUFv1DAQhS0EotvCD-CCLHHhEhhn1rFzrAq0lSrooZwtx550XSVOsJOq_Pt6tQUhpJ5G8vvmjWceY-8EfBIA6nMGQI0ViLrCGtoKXrCN2KKqWi3wJduAUOURpT5ixznfAYDGpn3NjmoUDbQgNixcRpfIZvLcuiXc2yVMkU89_3765fqCTw_BF5FveYh82RGf12Gcok2_-b3Nbh3ssibai_QwUwojxcUO3Ac775K9HYud4ztKMdg37FVvh0xvn-oJ-_nt683ZRXX14_zy7PSqcqjqpSJlXeNVr5VDDW0jnUQvGw2qAy0tCg9e9x5qXVaQXUsoukZ2UndeWY8ST9jHg--cpl8r5cWMITsaBhtpWrMRtUKhJOq2oB_-Q--mNcXyOyO2sFWNbGpRKHGgXJpyTtSbuSxaTmAEmH0O5pCDKTmYfQ4GSs_7J-e1G8n_7fhz-ALUByAXKd5S-mf0s66PWhuSQQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1404765621</pqid></control><display><type>article</type><title>Increased activation of NADPH oxidase 4 in the pulmonary vasculature in experimental diaphragmatic hernia</title><source>MEDLINE</source><source>SpringerLink</source><creator>Gosemann, Jan-H ; Friedmacher, Florian ; Hunziker, Manuela ; Alvarez, Luis ; Corcionivoschi, Nicolae ; Puri, Prem</creator><creatorcontrib>Gosemann, Jan-H ; Friedmacher, Florian ; Hunziker, Manuela ; Alvarez, Luis ; Corcionivoschi, Nicolae ; Puri, Prem</creatorcontrib><description>Aim Persistent pulmonary hypertension remains a major cause of mortality and morbidity in congenital diaphragmatic hernia (CDH). NADPH oxidases (Nox) are the main source of superoxide production in vasculature. Nox4 is highly expressed in the smooth muscle and endothelial cells of the vascular wall and increased activity has been reported in the pulmonary vasculature of both experimental and human pulmonary hypertension. Peroxisome proliferator-activated receptor (PPARγ) is a key regulator of Nox4 expression. Targeted depletion of PPARγ results in pulmonary hypertension phenotype whereas activation of PPARγ attenuates pulmonary hypertension and reduces Nox4 production. The nitrofen-induced CDH model is an established model to study the pathogenesis of pulmonary hypertension in CDH. It has been previously reported that PPARγ-signaling is disrupted during late gestation and H 2 O 2 production is increased in nitrofen-induced CDH. We designed this study to investigate the hypothesis that Nox4 expression and activation is increased and vascular PPARγ is decreased in nitrofen-induced CDH. Methods Pregnant rats were treated with either nitrofen or vehicle on gestational day 9 (D9). Fetuses were sacrificed on D21 and divided into control and CDH. RT-PCR, western blotting and confocal-immunofluorescence-double-staining were performed to determine pulmonary expression levels of PPARγ, Nox4 and Nox4-activation (p22 phox ). Results There was a marked increase in medial and adventitial thickness in pulmonary arteries of all sizes in CDH compared to controls. Pulmonary Nox4 levels were significantly increased whereas PPARγ levels were decreased in nitrofen-induced CDH compared to controls. Western blotting revealed increased pulmonary protein expression of the Nox4-activating subunit p22 phox and decreased protein expression of PPARγ in CDH compared to controls. Confocal-microscopy confirmed markedly increased pulmonary expression of the Nox4 activating subunit p22 phox accompanied by decreased perivascular PPARγ expression in lungs of nitrofen-exposed fetuses compared to controls. Conclusion To our knowledge, the present study is the first to report increased Nox4 production in the pulmonary vasculature of nitrofen-induced CDH. Down-regulation of the PPARγ-signaling pathway may lead to increased superoxide production, resulting in pulmonary vascular dysfunction and contributing to pulmonary hypertension in the nitrofen-induced CDH model. PPARγ-activation inhibiting Nox4 production may therefore represent a potential therapeutic approach for the treatment of pulmonary hypertension in CDH.</description><identifier>ISSN: 0179-0358</identifier><identifier>EISSN: 1437-9813</identifier><identifier>DOI: 10.1007/s00383-012-3209-0</identifier><identifier>PMID: 23160901</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer-Verlag</publisher><subject>Animals ; Blood Vessels - enzymology ; Female ; Hernia, Diaphragmatic - enzymology ; Lung - blood supply ; Medicine ; Medicine &amp; Public Health ; NADPH Oxidase 4 ; NADPH Oxidases - metabolism ; Original Article ; Pediatric Surgery ; Pediatrics ; Rats ; Rats, Sprague-Dawley ; Surgery</subject><ispartof>Pediatric surgery international, 2013, Vol.29 (1), p.3-8</ispartof><rights>Springer-Verlag Berlin Heidelberg 2012</rights><rights>Springer-Verlag Berlin Heidelberg 2013</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c372t-e7ac6d7f87c380965c53d56807b085a31d0d8fd0281605b9e31b65b58bd7ad353</citedby><cites>FETCH-LOGICAL-c372t-e7ac6d7f87c380965c53d56807b085a31d0d8fd0281605b9e31b65b58bd7ad353</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00383-012-3209-0$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00383-012-3209-0$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,780,784,27924,27925,41488,42557,51319</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23160901$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gosemann, Jan-H</creatorcontrib><creatorcontrib>Friedmacher, Florian</creatorcontrib><creatorcontrib>Hunziker, Manuela</creatorcontrib><creatorcontrib>Alvarez, Luis</creatorcontrib><creatorcontrib>Corcionivoschi, Nicolae</creatorcontrib><creatorcontrib>Puri, Prem</creatorcontrib><title>Increased activation of NADPH oxidase 4 in the pulmonary vasculature in experimental diaphragmatic hernia</title><title>Pediatric surgery international</title><addtitle>Pediatr Surg Int</addtitle><addtitle>Pediatr Surg Int</addtitle><description>Aim Persistent pulmonary hypertension remains a major cause of mortality and morbidity in congenital diaphragmatic hernia (CDH). NADPH oxidases (Nox) are the main source of superoxide production in vasculature. Nox4 is highly expressed in the smooth muscle and endothelial cells of the vascular wall and increased activity has been reported in the pulmonary vasculature of both experimental and human pulmonary hypertension. Peroxisome proliferator-activated receptor (PPARγ) is a key regulator of Nox4 expression. Targeted depletion of PPARγ results in pulmonary hypertension phenotype whereas activation of PPARγ attenuates pulmonary hypertension and reduces Nox4 production. The nitrofen-induced CDH model is an established model to study the pathogenesis of pulmonary hypertension in CDH. It has been previously reported that PPARγ-signaling is disrupted during late gestation and H 2 O 2 production is increased in nitrofen-induced CDH. We designed this study to investigate the hypothesis that Nox4 expression and activation is increased and vascular PPARγ is decreased in nitrofen-induced CDH. Methods Pregnant rats were treated with either nitrofen or vehicle on gestational day 9 (D9). Fetuses were sacrificed on D21 and divided into control and CDH. RT-PCR, western blotting and confocal-immunofluorescence-double-staining were performed to determine pulmonary expression levels of PPARγ, Nox4 and Nox4-activation (p22 phox ). Results There was a marked increase in medial and adventitial thickness in pulmonary arteries of all sizes in CDH compared to controls. Pulmonary Nox4 levels were significantly increased whereas PPARγ levels were decreased in nitrofen-induced CDH compared to controls. Western blotting revealed increased pulmonary protein expression of the Nox4-activating subunit p22 phox and decreased protein expression of PPARγ in CDH compared to controls. Confocal-microscopy confirmed markedly increased pulmonary expression of the Nox4 activating subunit p22 phox accompanied by decreased perivascular PPARγ expression in lungs of nitrofen-exposed fetuses compared to controls. Conclusion To our knowledge, the present study is the first to report increased Nox4 production in the pulmonary vasculature of nitrofen-induced CDH. Down-regulation of the PPARγ-signaling pathway may lead to increased superoxide production, resulting in pulmonary vascular dysfunction and contributing to pulmonary hypertension in the nitrofen-induced CDH model. PPARγ-activation inhibiting Nox4 production may therefore represent a potential therapeutic approach for the treatment of pulmonary hypertension in CDH.</description><subject>Animals</subject><subject>Blood Vessels - enzymology</subject><subject>Female</subject><subject>Hernia, Diaphragmatic - enzymology</subject><subject>Lung - blood supply</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>NADPH Oxidase 4</subject><subject>NADPH Oxidases - metabolism</subject><subject>Original Article</subject><subject>Pediatric Surgery</subject><subject>Pediatrics</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Surgery</subject><issn>0179-0358</issn><issn>1437-9813</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNp1kUFv1DAQhS0EotvCD-CCLHHhEhhn1rFzrAq0lSrooZwtx550XSVOsJOq_Pt6tQUhpJ5G8vvmjWceY-8EfBIA6nMGQI0ViLrCGtoKXrCN2KKqWi3wJduAUOURpT5ixznfAYDGpn3NjmoUDbQgNixcRpfIZvLcuiXc2yVMkU89_3765fqCTw_BF5FveYh82RGf12Gcok2_-b3Nbh3ssibai_QwUwojxcUO3Ac775K9HYud4ztKMdg37FVvh0xvn-oJ-_nt683ZRXX14_zy7PSqcqjqpSJlXeNVr5VDDW0jnUQvGw2qAy0tCg9e9x5qXVaQXUsoukZ2UndeWY8ST9jHg--cpl8r5cWMITsaBhtpWrMRtUKhJOq2oB_-Q--mNcXyOyO2sFWNbGpRKHGgXJpyTtSbuSxaTmAEmH0O5pCDKTmYfQ4GSs_7J-e1G8n_7fhz-ALUByAXKd5S-mf0s66PWhuSQQ</recordid><startdate>2013</startdate><enddate>2013</enddate><creator>Gosemann, Jan-H</creator><creator>Friedmacher, Florian</creator><creator>Hunziker, Manuela</creator><creator>Alvarez, Luis</creator><creator>Corcionivoschi, Nicolae</creator><creator>Puri, Prem</creator><general>Springer-Verlag</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>2013</creationdate><title>Increased activation of NADPH oxidase 4 in the pulmonary vasculature in experimental diaphragmatic hernia</title><author>Gosemann, Jan-H ; Friedmacher, Florian ; Hunziker, Manuela ; Alvarez, Luis ; Corcionivoschi, Nicolae ; Puri, Prem</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c372t-e7ac6d7f87c380965c53d56807b085a31d0d8fd0281605b9e31b65b58bd7ad353</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Animals</topic><topic>Blood Vessels - enzymology</topic><topic>Female</topic><topic>Hernia, Diaphragmatic - enzymology</topic><topic>Lung - blood supply</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>NADPH Oxidase 4</topic><topic>NADPH Oxidases - metabolism</topic><topic>Original Article</topic><topic>Pediatric Surgery</topic><topic>Pediatrics</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Surgery</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gosemann, Jan-H</creatorcontrib><creatorcontrib>Friedmacher, Florian</creatorcontrib><creatorcontrib>Hunziker, Manuela</creatorcontrib><creatorcontrib>Alvarez, Luis</creatorcontrib><creatorcontrib>Corcionivoschi, Nicolae</creatorcontrib><creatorcontrib>Puri, Prem</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Family Health Database (ProQuest)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Pediatric surgery international</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gosemann, Jan-H</au><au>Friedmacher, Florian</au><au>Hunziker, Manuela</au><au>Alvarez, Luis</au><au>Corcionivoschi, Nicolae</au><au>Puri, Prem</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Increased activation of NADPH oxidase 4 in the pulmonary vasculature in experimental diaphragmatic hernia</atitle><jtitle>Pediatric surgery international</jtitle><stitle>Pediatr Surg Int</stitle><addtitle>Pediatr Surg Int</addtitle><date>2013</date><risdate>2013</risdate><volume>29</volume><issue>1</issue><spage>3</spage><epage>8</epage><pages>3-8</pages><issn>0179-0358</issn><eissn>1437-9813</eissn><abstract>Aim Persistent pulmonary hypertension remains a major cause of mortality and morbidity in congenital diaphragmatic hernia (CDH). NADPH oxidases (Nox) are the main source of superoxide production in vasculature. Nox4 is highly expressed in the smooth muscle and endothelial cells of the vascular wall and increased activity has been reported in the pulmonary vasculature of both experimental and human pulmonary hypertension. Peroxisome proliferator-activated receptor (PPARγ) is a key regulator of Nox4 expression. Targeted depletion of PPARγ results in pulmonary hypertension phenotype whereas activation of PPARγ attenuates pulmonary hypertension and reduces Nox4 production. The nitrofen-induced CDH model is an established model to study the pathogenesis of pulmonary hypertension in CDH. It has been previously reported that PPARγ-signaling is disrupted during late gestation and H 2 O 2 production is increased in nitrofen-induced CDH. We designed this study to investigate the hypothesis that Nox4 expression and activation is increased and vascular PPARγ is decreased in nitrofen-induced CDH. Methods Pregnant rats were treated with either nitrofen or vehicle on gestational day 9 (D9). Fetuses were sacrificed on D21 and divided into control and CDH. RT-PCR, western blotting and confocal-immunofluorescence-double-staining were performed to determine pulmonary expression levels of PPARγ, Nox4 and Nox4-activation (p22 phox ). Results There was a marked increase in medial and adventitial thickness in pulmonary arteries of all sizes in CDH compared to controls. Pulmonary Nox4 levels were significantly increased whereas PPARγ levels were decreased in nitrofen-induced CDH compared to controls. Western blotting revealed increased pulmonary protein expression of the Nox4-activating subunit p22 phox and decreased protein expression of PPARγ in CDH compared to controls. Confocal-microscopy confirmed markedly increased pulmonary expression of the Nox4 activating subunit p22 phox accompanied by decreased perivascular PPARγ expression in lungs of nitrofen-exposed fetuses compared to controls. Conclusion To our knowledge, the present study is the first to report increased Nox4 production in the pulmonary vasculature of nitrofen-induced CDH. Down-regulation of the PPARγ-signaling pathway may lead to increased superoxide production, resulting in pulmonary vascular dysfunction and contributing to pulmonary hypertension in the nitrofen-induced CDH model. PPARγ-activation inhibiting Nox4 production may therefore represent a potential therapeutic approach for the treatment of pulmonary hypertension in CDH.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer-Verlag</pub><pmid>23160901</pmid><doi>10.1007/s00383-012-3209-0</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0179-0358
ispartof Pediatric surgery international, 2013, Vol.29 (1), p.3-8
issn 0179-0358
1437-9813
language eng
recordid cdi_proquest_miscellaneous_1273175389
source MEDLINE; SpringerLink
subjects Animals
Blood Vessels - enzymology
Female
Hernia, Diaphragmatic - enzymology
Lung - blood supply
Medicine
Medicine & Public Health
NADPH Oxidase 4
NADPH Oxidases - metabolism
Original Article
Pediatric Surgery
Pediatrics
Rats
Rats, Sprague-Dawley
Surgery
title Increased activation of NADPH oxidase 4 in the pulmonary vasculature in experimental diaphragmatic hernia
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T14%3A56%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Increased%20activation%20of%20NADPH%20oxidase%204%20in%20the%20pulmonary%20vasculature%20in%20experimental%20diaphragmatic%20hernia&rft.jtitle=Pediatric%20surgery%20international&rft.au=Gosemann,%20Jan-H&rft.date=2013&rft.volume=29&rft.issue=1&rft.spage=3&rft.epage=8&rft.pages=3-8&rft.issn=0179-0358&rft.eissn=1437-9813&rft_id=info:doi/10.1007/s00383-012-3209-0&rft_dat=%3Cproquest_cross%3E3024103411%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1404765621&rft_id=info:pmid/23160901&rfr_iscdi=true